REQUEST A DEMO
Total
USD $0.00
Search more companies

Dibbana Pharma S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dibbana Pharma S.A.S Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Dibbana Pharma S.A.S is a company based in Colombia, with its head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on March 29, 2019. It currently has a total number of 2 (2023) employees. From the latest financial highlights, Dibbana Pharma S.A.S reported a net sales revenue increase of 16.23% in 2022. Its’ total assets recorded a growth of 26.91%. The net profit margin of Dibbana Pharma S.A.S decreased by 0.72% in 2022.

Headquarters
Cl 79B # 5 81 Ofc 404
Bogota D.C.; Bogota D.C; Postal Code: 0801

Contact Details: Purchase the Dibbana Pharma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Dibbana Pharma S.A.S report to view the information.
Outstanding Shares:
Purchase the Dibbana Pharma S.A.S report to view the information.
Incorporation Date:
March 29, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Dibbana Pharma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
16.23%
Total operating revenue
16.23%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-69.86%
Total assets
26.91%
Total equity
-9.57%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.72%
Return on Equity (ROE)
-4.95%
Quick Ratio
-1.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?